Share this article Share this article BATON ROUGE, La., Feb. 4, 2021 /PRNewswire/ -- University Products, LLC recently noted a survey of ranchers and farmers detailing the most-preferred strategies for helping control the spread of anaplasmosis in U.S. herds. Anaplasmosis is a blood disease carried by parasites that infects red blood cells and causes severe anemia and death, representing a major annual financial loss to ranchers and the beef industry. University Products, LLC is the maker and distributor of a bovine anaplasmosis vaccine successfully tested and deployed since 2000. Respondents to the anaplasmosis survey fell into three main categories: 78% chose vaccination as a main strategy to deploy, 14% chose chlortetracycline (CTC) treatments, 5% chose testing, and 3% chose other. CTC is a broad-spectrum antibiotic usually given in a variety of feeding levels and is used in beef cattle, non-lactating dairy cattle, and sheep. CTC has traditionally been the medical treatment of choice, often deployed as a preventative or after cattle are already infected and begin to show signs of disease. CTC cannot be used in every cattle-producing country however, and recent antibiotic resistance, updated FDA regulations, and consumer trends in the agricultural industry are also beginning to shift producers away from consistent antibiotic use as a preventative measure.